ATE196147T1 - Wachstumsdifferenzierungsfaktor-12 - Google Patents

Wachstumsdifferenzierungsfaktor-12

Info

Publication number
ATE196147T1
ATE196147T1 AT95928062T AT95928062T ATE196147T1 AT E196147 T1 ATE196147 T1 AT E196147T1 AT 95928062 T AT95928062 T AT 95928062T AT 95928062 T AT95928062 T AT 95928062T AT E196147 T1 ATE196147 T1 AT E196147T1
Authority
AT
Austria
Prior art keywords
pct
differentiation factor
growth differentiation
gdf
sec
Prior art date
Application number
AT95928062T
Other languages
English (en)
Inventor
Se-Jin Lee
Aurora F Esquela
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/274,215 external-priority patent/US5831054A/en
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Application granted granted Critical
Publication of ATE196147T1 publication Critical patent/ATE196147T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95928062T 1994-07-13 1995-07-12 Wachstumsdifferenzierungsfaktor-12 ATE196147T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/274,215 US5831054A (en) 1994-07-13 1994-07-13 Polynucleotide encoding growth differentiation factor-12
US31137094A 1994-09-26 1994-09-26
PCT/US1995/008745 WO1996002559A1 (en) 1994-07-13 1995-07-12 Growth differentiation factor-12

Publications (1)

Publication Number Publication Date
ATE196147T1 true ATE196147T1 (de) 2000-09-15

Family

ID=26956672

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95928062T ATE196147T1 (de) 1994-07-13 1995-07-12 Wachstumsdifferenzierungsfaktor-12

Country Status (11)

Country Link
US (1) US5929213A (de)
EP (1) EP0770089B1 (de)
JP (1) JPH10503362A (de)
AT (1) ATE196147T1 (de)
CA (1) CA2195246A1 (de)
DE (1) DE69518760T2 (de)
DK (1) DK0770089T3 (de)
ES (1) ES2151607T3 (de)
GR (1) GR3034772T3 (de)
PT (1) PT770089E (de)
WO (1) WO1996002559A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
ATE319823T1 (de) 1993-12-07 2006-03-15 Inst Genetics Llc Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin
US5965403A (en) 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6027917A (en) 1997-12-10 2000-02-22 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
DK1223990T3 (da) 1999-10-15 2004-11-29 Inst Genetics Llc Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
CN1250288C (zh) * 1999-12-15 2006-04-12 研究发展基金会 作为抑制素受体的β聚糖及其用途
EP1399023B1 (de) 2001-06-01 2008-04-30 Wyeth Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
CN101897974B (zh) 2003-09-12 2013-09-25 惠氏公司 用于递送成骨蛋白的注射型磷酸钙固体小棒剂和糊剂
EP1740609A2 (de) 2004-04-27 2007-01-10 Research Development Foundation Antagonismus des tgf-beta superfamily signal rezeptors
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
WO2007092622A2 (en) 2006-02-09 2007-08-16 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
WO2008005427A2 (en) 2006-06-30 2008-01-10 Biomimetic Therapeutics, Inc. Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US8524265B2 (en) 2006-08-17 2013-09-03 Warsaw Orthopedic, Inc. Medical implant sheets useful for tissue regeneration
BRPI0918611B8 (pt) 2008-09-09 2021-06-22 Biomimetic Therapeutics Inc composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
US8609127B2 (en) 2009-04-03 2013-12-17 Warsaw Orthopedic, Inc. Medical implant with bioactive material and method of making the medical implant
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
CN102811622A (zh) 2010-02-22 2012-12-05 生物模拟治疗公司 用于治疗腱病的血小板衍生生长因子组合物和方法
WO2014012101A1 (en) 2012-07-13 2014-01-16 Trustees Of Tufts College Silk powder compaction for production of constructs with high mechanical strength and stiffness
JP7025021B2 (ja) 2015-10-26 2022-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 還元多糖および酸化多糖ならびにそれらの使用の方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ249113A (en) * 1992-02-12 1996-07-26 Bioph Biotech Entw Pharm Gmbh Recombinant dna encoding tgf-b, its production and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP0770089A1 (de) 1997-05-02
US5929213A (en) 1999-07-27
GR3034772T3 (en) 2001-02-28
JPH10503362A (ja) 1998-03-31
PT770089E (pt) 2001-02-28
DE69518760T2 (de) 2001-05-23
ES2151607T3 (es) 2001-01-01
CA2195246A1 (en) 1996-02-01
EP0770089A4 (de) 1997-06-18
DK0770089T3 (da) 2000-10-23
WO1996002559A1 (en) 1996-02-01
EP0770089B1 (de) 2000-09-06
DE69518760D1 (de) 2000-10-12

Similar Documents

Publication Publication Date Title
DE69518760D1 (de) Wachstumsdifferenzierungsfaktor-12
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
EP1559726A3 (de) Wachstumsdifferenzierungsfaktor-10
EP1475440A3 (de) Wachstums-Differentierungsfaktor-3
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
DE69632236D1 (de) Verwendung von dha in der behandlung von dyslexie
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
SE8902532L (sv) Bestaemning av plasmaproteiner
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
DE69838509D1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
DE69232483D1 (de) Mycobacteriumprotein und dessen verwendung
EP0227619A3 (de) Protein und seine Anwendung
SE9402880D0 (sv) New peptide derivatives
EP0960117A4 (de) ZU FIBROBLASTEN-WACHSTUMSFAKTOR HOMOLOGE FAKTOREN (FHFs) UND VERFAHREN DER ANWENDUNG
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
EP0266993A3 (en) Method and therapeutic compositions for the treatment of bleeding disorders
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
PT870036E (pt) Α-n-acetilglucosaminidase de mamífero sintética e sequências genéticas codificando a mesma
EP0832109A4 (de) Faktor-2, homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung
DE68914397D1 (de) Menschliches Lymphotoxin.
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
PT788549E (pt) Sequencias reguladoras de acidos nucleicos e utilizacoes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee